J&J Is Focused on Fighting Cancer, Not Obesity Drugs, CEO Says

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.